Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Blauvelt Andrew and de Bruin-Weller Marjolein and Gooderham Melinda and Cather Jennifer C and Weisman Jamie and Pariser David and Simpson Eric L and Papp Kim A and Hong H Chih-Ho and Rubel Diana and Foley Peter and Prens Errol and Griffiths Christopher E M and Etoh Takafumi and Pinto Pedro Herranz and Pujol Ramon M and Szepietowski Jacek C and Ettler Karel and Kemény Lajos and Zhu Xiaoping and Akinlade Bolanle and Hultsch Thomas and Mastey Vera and Gadkari Abhijit and Eckert Laurent and Amin Nikhil and Graham Neil M H and Pirozzi Gianluca and Stahl Neil and Yancopoulos George D and Shumel Brad: Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
LANCET, 389 (10086). pp. 2287-2303. ISSN 0140-6736 (2017)

Actions (login required)